Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are seeing a doctor because you or someone close to you has noticed problems with your thinking or memory, OR your doctor suspects you may have a progressive brain condition such as Alzheimer's disease or a similar illness.
- Your main concern is memory problems, but it could also be difficulties with organisation, finding words, seeing and understanding your surroundings, or staying focused.
- You are 40 years old or older.
- You have been found to have mild or early-stage thinking and memory difficulties, ranging from slight personal concerns about your cognition to mild dementia.
Who may not be able to join:
- You have already been given a formal diagnosis of dementia.
- You have a serious ongoing physical illness or organ problem that would make it hard to take part in the trial.
- You are currently misusing alcohol or other substances in a significant way.
- You are not willing to be assessed at a Memory clinic.
- Your thinking and memory problems started suddenly as a direct result of a stroke.
- Your thinking and memory difficulties can be clearly and fully explained by another condition, such as severe anaemia, an infection, serious lack of sleep, a psychotic disorder, moderate to severe depression, or alcohol misuse.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erik Stomrud, MD, PhD, Skane University Hospital and Lund University
Phone: +46-40-331000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence of brain AD pathology as determined by CSF AD biomarkers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.